Institutional Ownership
Rigel Pharmaceuticals Inc
CUSIP 766559702COMRIGLQ1 2026
13D / 13G Filings
12
Schedule 13D/13G on record
Beneficial Filers
7
Distinct reporting persons
Largest Stake
9.9%
Max % of class reported
Institutional Holders
142
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
12 filings · latest Feb 9, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 9, 2026 | State Street Corporation | 13G | 6.0% | 1.09M | SEC |
| 2 | Oct 7, 2025 | Morgan Stanley | 13G/A | 0.7% | 116.4K | SEC |
| 3 | Aug 5, 2025 | Soleus Capital Master Fund, L.P. | 13G/A | 3.7% | 658.1K | SEC |
| 4 | May 15, 2025 | Armistice Capital, LLC | 13G/A | 8.5% | 1.52M | SEC |
| 5 | Apr 17, 2025 | Blackrock, Inc. | 13G/A | 7.7% | 1.38M | SEC |
| 6 | Feb 14, 2025 | Armistice Capital, LLC | 13G/A | 6.5% | 1.15M | SEC |
| 7 | Feb 11, 2025 | Soleus Capital Master Fund, L.P. | 13G/A | 6.4% | 1.13M | SEC |
| 8 | Feb 7, 2025 | Invesco Ltd. | 13G/A | — | 6.4K | SEC |
| 9 | Feb 5, 2025 | Blackrock, Inc. | 13G | 9.9% | 1.75M | SEC |
| 10 | Nov 14, 2024 | Soleus Capital Master Fund, L.P. | 13G/A | 5.3% | 934.8K | SEC |
2 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Rigel Pharmaceuticals Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 1.77M | $47.83M |
| 2 | Armistice Capital, LLC | 1.28M | $34.61M |
| 3 | State Street Corp | 1.12M | $30.29M |
| 4 | Marshall Wace, LLP | 598.4K | $16.18M |
| 5 | American Century Companies Inc | 544.4K | $14.72M |
| 6 | D. E. Shaw & Co., Inc. | 445.7K | $12.05M |
| 7 | Geode Capital Management, LLC | 440.6K | $11.92M |
| 8 | Goldman Sachs Group Inc | 439.1K | $11.87M |
| 9 | Two Sigma Investments, LP | 405.8K | $10.97M |
| 10 | Dimensional Fund Advisors LP | 379.5K | $10.26M |